Significantly increased antibody response to heterogeneous nuclear ribonucleoproteins in cerebrospinal fluid of multiple sclerosis patients but not in patients with human T-lymphotropic virus type I - Associated myelopathy/tropical spastic paraparesis

Journal of NeuroVirology

Volumn 14, Issue 2, 2008, Pages 130-135

  Yukitake, Motohiro ^a   Sueoka, Eisaburo ^a   Sueoka Aragane, Naoko ^a   Sato, Akemi ^b   Ohashi, Hiromi ^a   Yakushiji, Yusuke ^a   Saito, Mineki ^b   Osame, Mitsuhiro ^c   Izumo, Shuji ^c   Kuroda, Yasuo ^a  

^a SAGA UNIVERSITY   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Anti hnRNP A1 antibody; Anti hnRNP A2 B1 antibody; Cerebrospinal fluid; HTLV I associated myelopathy tropical spastic paraparesis; Multiple sclerosis

Indexed keywords

HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; RIBONUCLEOPROTEIN A1 ANTIBODY; RIBONUCLEOPROTEIN A2 ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY; RIBONUCLEOPROTEIN B2 ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOREACTIVITY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SCHOOL CHILD; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; VIRUS VIRULENCE;

ANTIBODY FORMATION; AUTOANTIBODIES; BRAIN; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HTLV-I ANTIBODIES; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MULTIPLE SCLEROSIS; PARAPARESIS, TROPICAL SPASTIC; RANDOM ALLOCATION;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 42949106453     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280701883840     Document Type: Article

References (27)

1. Berger, T., Rubner, P., Schautzer, F., Egg, R., Ulmer, H., Mayringer, I., Dilitz, E., Deisenhammer, F. and Reindl, M. (2003) Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N Engl J Med, 349, pp. 139-145.
2. Brumwell, C., Antolik, C., Carson, J. H. and Barbarese, E. (2002) Intracellular trafficking of hnRNP A2 in oligodendrocytes. Exp Cell Res, 279, pp. 310-320.
3. Burd, C. G. and Dreyfuss, G. (1994) Conserved structures and diversity of functions of RNA-binding proteins. Science, 265, pp. 615-621.
4. Couratier, P., Yi, F. H., Preud'homme, J. L., Clavelou, P., White, A., Sindou, P., Vallat, J. M. and Jauberteau, M. O. (1998) Serum autoantibodies to neurofilament proteins in sporadic amyotrophic lateral sclerosis. J Neurol Sci, 154, pp. 137-145.
5. Greidinger, E. L., Gazitt, T., Jaimes, K. F. and Hoffman, R. W. (2004) Human T cell clones specific for heterogeneous nuclear ribonucleoprotein A2 autoantigen from connective tissue disease patients assist in autoantibody production. Arthritis Rheum, 50, pp. 2216-2222.
6. Hanon, E., Goon, P., Taylor, G. P., Hasegawa, H., Tanaka, Y., Weber, J. N. and Bangham, C. R. (2001) High production of interferon but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells. Blood, 98, pp. 721-726.
7. Hassfeld, W., Steiner, G., Studnicka-Benke, A., Skriner, K., Graninger, W., Fischer, I. and Smolen, J. S. (1995) Autoimmune response to the spliceosome. An immunologic link between rheumatoid arthritis, mixed connective tissue disease and systemic lupus erythematosus. Arthritis Rheum, 38, pp. 777-785.
8. Izumo, S., Goto, I., Itoyama, Y., Okajima, T., Watanabe, S., Kuroda, Y., Araki, S., Mori, M., Nagataki, S., Matsukura, S., Akamine, T., Nakagawa, M., Yamamoto, I. and Osame, M. (1996) Interferon-alpha is effective in HTLV-I-associated myelopathy: A multicenter, randomized, double-blind, controlled trial. Neurology, 46, pp. 1016-1021.
9. Jacobson, S., Shida, H., McFarlin, D. E., Fauci, A. S. and Koenig, S. (1990) Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature, 348, pp. 245-248.
10. Jernigan, M., Morcos, Y., Lee, S. M., Dohan Jr, F. C., Raine, C. and Levin, M. C. (2003) IgG in brain correlates with clinicopathological damage in HTLV-1 associated neurologic disease. Neurology, 60, pp. 1320-1327.
11. Jones, D. A., Yawalkar, N., Suh, K. Y., Sadat, S., Rich, B. and Kupper, T. S. (2004) Identification of autoantigens in psoriatic plaques using expression cloning. J Invest Dermatol, 123, pp. 93-100.
12. Krecic, A. M. and Swanson, M. S. (1999) hnRNP complexes: Composition, structure, and function. Curr Opin Cell Biol, 11, pp. 363-371.
13. Kuroda, Y., Matsui, M., Yukitake, M., Kurohara, K., Takashima, H., Takashima, Y., Endo, C., Kato, A. and Mihara, F. (1995) Assessment of MRI criteria for MS in Japanese MS and HAM/TSP. Neurology, 45, pp. 30-33.
14. Levin, M. C., Krichavsky, M., Berk, J., Foley, S., Rosenfeld, M., Dalmau, J., Chang, G., Posner, J. B. and Jacobson, S. (1998) Neuronal molecular mimicry in immune-mediated neurologic disease. Ann Neurol, 44, pp. 87-98.
15. Levin, M. C., Lee, S. M., Kalume, F., Morcos, Y., Dohan Jr, F. C., Hasty, K. A., Callaway, J. C., Zunt, J., Desiderio, D. and Stuart, J. M. (2002) Autoimmunity due to molecular mimicry as a cause of neurological disease. Nat Med, 8, pp. 509-513.
16. Maggipinto, M., Rabiner, C., Kidd, G. J., Hawkins, A. J., Smith, R. and Barbarese, E. (2004) Increased expression of the MBP mRNA binding protein hnRNP A2 during oligodendrocyte differentiation. J Neurosci Res, 75, pp. 614-623.
17. McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H. P., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., Sandberg-Wollheim, M., Sibley, W., Thompson, A., Noort, S van den, Weinshenker, B. Y. and Wolinsky, J. S. (2001) Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol, 50, pp. 121-127.
18. Meyer, O., Tauxe, F., Fabregas, D., Gabay, C., Goycochea, M., Haim, T., Elias, A. and Kahn, M. F. (1993) Anti-RA33 antinuclear autoantibody in rheumatoid arthritis and mixed connective tissue disease: Comparison with antikeratin and antiperinuclear antibodies. Clin Exp Rheumatol, 11, pp. 473-478.
19. Munro, T. P., Magee, R. J., Kidd, G. J., Carson, J. H., Barbarese, E., Smith, L. M. and Smith, R. (1999) Mutational analysis of a nuclear ribonucleoprotein A2 response element for RNA trafficking. J Biol Chem, 274, pp. 34389-34395.
20. Nagai, M. and Jacobson, S. (2001) Immunopathogenesisi of human T cell lymphotropic virus type I-associated myelopathy. Curr Opin Neurol, 14, pp. 381-386.
21. Noseworthy, J. H., Lucchinetti, C., Rodriguez, M. and Weinshenker, B. G. (2000) Multiple sclerosis. N Engl J Med, 343, pp. 938-952.
22. Osame, M. (1990) Review of WHO Kagoshima Meeting and Diagnostic guidelines for HAM/TSP. Human retrovirology: HTLV, pp. 191-197. Raven Press, New York
23. Osame, M. (2002) Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM/TSP). J NeuroVirol, 8, pp. 359-364.
24. Steiner, G., Hartmuth, K., Skriner, K., Maurer-Fogy, I., Sinski, A., Thalmann, E., Hassfeld, W., Barta, A. and Smolen, J. S. (1992) Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. J Clin Invest, 90, pp. 1061-1066.
25. Steinman, L. (1996) Multiple sclerosis: A coordinated immunological attack against myelin in the central nervous system. Cell, 85, pp. 299-302.
26. Sueoka, E., Sueoka, N., Goto, Y., Matsuyama, S., Nishimura, H., Sato, M., Fujimura, S., Chiba, H. and Fujiki, H. (2001) Heterogeneous nuclear ribonucleoprotein B1 as early cancer biomarker for occult cancer of human lungs and bronchial dysplasia. Cancer Res, 61, pp. 1896-1902.
27. Sueoka, E., Yukitake, M., Iwanaga, K., Sueoka, N., Aihara, T. and Kuroda, Y. (2004) Autoantibodies against heterogeneous nuclear ribonucleoprotein B1 in CSF of MS patients. Ann Neurol, 56, pp. 778-786.